Head to head
China Pharma vs World Monitor
Same numbers we show everywhere else, lined up. Ratings come from users, the grade comes from our scanner, adoption comes from public registries.
No reviews yet
China Pharma MCP — China-to-Western biotech licensing deals, from SEC filings.
Full listing
No reviews yet
Live markets, conflicts, country risk, chokepoints, energy, and China decision signals. 75 tools.
Full listingThe short version
Neither has been reviewed yet, so the comparison rests on the scan and the public usage numbers. The safety scan favours World Monitor (95/100 against 77). World Monitor has noticeably more public adoption.
| China Pharma | World Monitor | |
|---|---|---|
| User rating | No reviews yet | No reviews yet |
| Safety grade | B77/100 | A95/100 |
| Adoption | Growing | Widely used |
| GitHub stars | 0 | 87k |
| Downloads / week | – | – |
| Runs where | Hosted (remote) | Hosted (remote) |
| Gateway-ready | Yes | Yes |
| Tools | 41 | — |
| Write actions | 4 | — |
| Price per call | Free | Free |
| Licence | MIT | AGPL-3.0 |
| Last release | 2026-09-19 | 2026-09-19 |
| Category | Everything else | Everything else |